Delisting Determination, The Nasdaq Stock Market, LLC,
July 19, 2022,  Zosano Pharma Corporation. The Nasdaq
Stock Market LLC (the Exchange) has determined to remove
from listing the common stock of Zosano Pharma Corporation,
effective at the opening of the trading session on July 29, 2022.
Based on review of information provided by the Company, Nasdaq Staff
determined that the Company no longer qualified for listing on the
Exchange pursuant to Listing Rules 5101, 5110(b), and IM-5101-1.
The Company was notified of the Staff determination on
June 2, 2022. The Company did not appeal the Staff
determination to the Hearings Panel. The Listing Council
did not call the matter for review. The Staff determination
to delist the Company common stock became final on
June 13, 2022.